Product Description
Overall, the global syringe and needle market was valued at $5.1 billion in 2023. This is expected to increase over the forecast period at a CAGR of 1.3% to reach $5.6 billion.
Throughout this medical market research, we analyzed over 30 syringe and needle companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for catheter securement includes two distinct segments: syringes and needles. The syringe segment includes both conventional syringes and safety syringes. On the other hand, the needle segment covers conventional needles, safety needles and blunt fill needles.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Syringe and Needle Market Insights
Rising vaccination rates have led to an increased demand for syringes and traditional needles. These vaccines cater to various illnesses, such as protection against human papillomavirus (HPV), hepatitis, and other diseases. Back in 2009, the surge in demand for vaccines to combat the H1N1 virus was notable. To address this, the U.S. government procured around 200 million H1N1 flu vaccine doses from manufacturers, aiming to vaccinate two-thirds of the population. With vaccinations becoming more commonplace, this trend will continue to propel the syringe and needle market.
Global Syringe and Needle Market Share Insight
In 2023, Becton Dickinson (BD) continued to dominate the syringe and needle market, primarily within the hospital segment, accounting for over half of total sales. Their extensive production capacity enabled the provision of syringes at competitive prices. BD’s product portfolio boasted SafetyGlide™ shielding hypodermic needles, Eclipse™ pivoting injection needles, and Integra™ retractable syringes.
Following closely behind, Cardinal Health secured the position of the second-largest competitor, making significant strides in the market after acquiring Medtronic’s Patient Care division. This acquisition allowed Cardinal Health to offer the Monoject™ and Magellan™ lines, both retrofitted as safety devices, boosting their standing in the industry.
In 2023, B. Braun held the third spot among competitors in the syringe and needle market. The company had experienced substantial growth in market share, particularly in regions like Germany, France, and the United Kingdom over recent years. B. Braun’s product line includes standard and fine-dose two-part and three-part syringes.
Market Segmentation Summary
- Global Syringe Market – Includes:
- Conventional Syringes and Safety Syringes.
- Global Needle Market – Includes:
- Conventional Needled, Safety Needles, and Blunt Fill Needles.
Global Research Scope Summary
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2023 |
Forecast | 2024-2030 |
Historical Data | 2020-2023 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
Contact Us For Additional Information
For full segmentation and any questions regarding research coverage, please contact us or send a request by pressing one of the buttons below.